Impaired [ftcn]
Fibrinolysis [phsf]
premenopausal [tmco]
Women [popg]
Age [orga]
matched [resa]
Men [popg]
Diabetes Mellitus, Type 2 [dsyn]
Pilot Study [resa]
Diabetes Mellitus, Type 2 [dsyn]
Strong [qlco]
Cardiovascular disease [dsyn]
Women [popg]
Specific [qlco]
Mechanisms [ftcn]
Increased [qnco]
Unknown [qlco]
Contribute [acty]
Cardiovascular disease [dsyn]
Women [popg]
Diabetes Mellitus, Type 2 [dsyn]
Impaired [ftcn]
Fibrinolysis [phsf]
Health [idcn]
premenopausal [tmco]
Women [popg]
Cardiovascular disease [dsyn]
Excellent [qlco]
fibrinolytic [topp]
Impairment [patf]
Fibrinolysis [phsf]
People [popg]
Diabetes Mellitus [dsyn]
Men [popg]
fibrinolytic [topp]
Women [popg]
Diabetes Mellitus, Type 2 [dsyn]
Characterized [acty]
Well [qlco]
Pilot Study [resa]
Compared [acty]
fibrinolytic [topp]
Measures [qnco]
premenopausal [tmco]
Women [popg]
Men [popg]
Diabetes Mellitus [dsyn]
Healthy Control [qlco]
Age [orga]
matched [resa]
Women [popg]
Men [popg]
Help [socb]
Fibrinolysis [phsf]
Abnormal [qlco]
Women [popg]
Diabetes Mellitus [dsyn]
Methods [inpr]
fibrinolytic [topp]
measurements [ftcn]
included [ftcn]
Euglobulin Clot Lysis Time [lbpr]
Fibrinogen [aapp, bacs, phsu]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
Euglobulin Clot Lysis Time [lbpr]
Impaired [ftcn]
Women [popg]
Diabetes Mellitus [dsyn]
Compared [acty]
Women [popg]
Men [popg]
Diabetes Mellitus [dsyn]
Slow [qlco]
Euglobulin Clot Lysis Time [lbpr]
Men [popg]
Men [popg]
Group [idcn]
Not significant [fndg]
Women [popg]
Group [idcn]
Observed [ftcn]
trend [tmco]
Increased [qnco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Women [popg]
Diabetes Mellitus [dsyn]
Conclusions [idcn]
Women [popg]
Diabetes Mellitus [dsyn]
Abnormality [fndg]
Euglobulin Clot Lysis Time [lbpr]
Men [popg]
Diabetes Mellitus [dsyn]
Compared [acty]
Sex [orgf]
Specific [qlco]
Diabetes Mellitus [dsyn]
